| scholarly article | Q13442814 |
| P2093 | author name string | Shuguang Wang | |
| Helen B Hartman | |||
| Mark J Evans | |||
| Franklin J Moy | |||
| KehDih Lai | |||
| Anitha Bhat | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4025-4033 | |
| P577 | publication date | 2006-05-04 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone | |
| P478 | volume | 147 |
| Q35993511 | Age-Related Changes of Plasma Bile Acid Concentrations in Healthy Adults--Results from the Cross-Sectional KarMeN Study |
| Q47993005 | Androgens modulate male-derived endothelial cell homeostasis using androgen receptor-dependent and receptor-independent mechanisms |
| Q28085493 | Bile acid nuclear receptor FXR and digestive system diseases |
| Q41537786 | Bile acid-FXRα pathways regulate male sexual maturation in mice |
| Q43050570 | Characterization of porcine pregnane X receptor, farnesoid X receptor and their splice variants |
| Q57292627 | Crosstalk between BPA and FXRα Signaling Pathways Lead to Alterations of Undifferentiated Germ Cell Homeostasis and Male Fertility Disorders |
| Q93200745 | Evidence for the involvement of FXR signaling in ovarian granulosa cell function |
| Q37376356 | FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression |
| Q37334984 | FXR an emerging therapeutic target for the treatment of atherosclerosis |
| Q37006382 | FXR signaling in metabolic disease |
| Q27014753 | FXR signaling in the enterohepatic system |
| Q37282312 | FXR: a metabolic regulator and cell protector |
| Q37353652 | Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice |
| Q28266284 | Farnesoid X receptor: from medicinal chemistry to clinical applications |
| Q39906689 | Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy |
| Q30422089 | Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation. |
| Q43512543 | Monitoring bile acid transport in single living cells using a genetically encoded Förster resonance energy transfer sensor. |
| Q38110503 | Nuclear receptor control of enterohepatic circulation. |
| Q36786270 | Nuclear receptors as drug targets in cholestatic liver diseases |
| Q34694229 | Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications |
| Q38095223 | Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate |
| Q38265728 | Role of farnesoid X receptor in inflammation and resolution. |
| Q24649074 | Role of microsomal retinol/sterol dehydrogenase-like short-chain dehydrogenases/reductases in the oxidation and epimerization of 3alpha-hydroxysteroids in human tissues |
| Q30395192 | Role of nuclear receptor SHP in metabolism and cancer |
| Q42253372 | Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors |
| Q47778761 | The farnesoid X receptor FXRalpha/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolution |
| Q37184702 | The farnesoid X receptor regulates transcription of 3beta-hydroxysteroid dehydrogenase type 2 in human adrenal cells |
| Q37300843 | The role of FXR in disorders of bile acid homeostasis |
| Q30444553 | The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice |
| Q42644100 | Uncovering the embryonic development-related proteome and metabolome signatures in breast muscle and intramuscular fat of fast-and slow-growing chickens |
| Q37378541 | Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome. |
Search more.